-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BrZ+fsftaEd3WDf24Z0kEfmR3rZytx5UKEma4cyiN7YbrDEekZ1mTSeuxL1Nivwb 5qw6hV3xHbshJfkigeysHA== 0000912057-97-015754.txt : 19970507 0000912057-97-015754.hdr.sgml : 19970507 ACCESSION NUMBER: 0000912057-97-015754 CONFORMED SUBMISSION TYPE: 10-K/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19961231 FILED AS OF DATE: 19970506 SROS: NASD FILER: COMPANY DATA: COMPANY CONFORMED NAME: NORLAND MEDICAL SYSTEMS INC CENTRAL INDEX KEY: 0000946428 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826] IRS NUMBER: 061387931 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 000-26206 FILM NUMBER: 97596223 BUSINESS ADDRESS: STREET 1: 106 CORPORATE PARK DRIVE STREET 2: SUITE 106 CITY: WHITE PLAINS STATE: NY ZIP: 10604 BUSINESS PHONE: 914-694-2285 MAIL ADDRESS: STREET 1: 106 CORPORATE PARK DRIVE STREET 2: SUITE 106 CITY: WHITE PLAINS STATE: NY ZIP: 10604 FORMER COMPANY: FORMER CONFORMED NAME: OSTECH INC DATE OF NAME CHANGE: 19950608 10-K/A 1 FORM 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 1996 Commission File No. 0-26206 NORLAND MEDICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter) DELAWARE 06-1387931 (State or other jurisdiction (I.R.S. Employer of incorporation or organization) Identification No.) 106 CORPORATE PARK DRIVE, SUITE 106, WHITE PLAINS, NY 10604 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: (914) 694-2285 Securities registered pursuant to Section 12(b) of the Act: NONE Securities registered pursuant to Section 12(g) of the Act: COMMON STOCK, PAR VALUE $0.0005 PER SHARE Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No --- --- Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein, and will not be contained, to the best of registrant's knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K [ ] The aggregate market value of the registrant's Common Stock, par value $0.0005 per share, held by non-affiliates of the registrant as of March 21, 1997 was $23,555,584 based on the price of the last reported sale on the NASDAQ National Market. As of March 21, 1997 there were 7,148,531 shares of the registrant's Common Stock, par value $0.0005 per share, outstanding. This Form 10-K/A Report amends the Form 10-K Report filed by the Registrant with the Securities and Exchange Commission on March 31, 1997 (the "Original Report"), as amended by Form 10-K/A filed on April 30, 1997. The purpose of this amendment is to add Exhibit 27, the Financial Data Schedule, which was inadvertently omitted from the Original Report. PART IV ITEM 14. EXHIBITS, FINANCIAL STATEMENT SCHEDULES AND REPORTS ON FORM 8-K. (b) Exhibits. Item 14(b) is amended to add the following Exhibit: Exhibit Number Description - ------- ----------- 27 Financial Data Schedule 2 SIGNATURES Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this Amendment to its Annual Report to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of White Plains, New York, on the 5th day of May, 1997. NORLAND MEDICAL SYSTEMS, INC. By: /s/ Reynald G. Bonmati ------------------------------- Name: Reynald G. Bonmati Title: President Pursuant to the requirements of the Securities Exchange Act of 1934, this Amendment to Annual Report has been signed below by the following persons on behalf of the Registrant, Norland Medical Systems, Inc., in the capacities and on the dates indicated. Capacity In Signature Which Signed Date --------- ------------ ---- /s/ Reynald G. Bonmati Chairman of the Board and May 5, 1997 ------------------------ President (Principal Executive Reynald G. Bonmati Officer); and Director /s/ Kurt W. Streams Vice President, Finance May 5, 1997 ------------------------ (Principal Financial Officer and Kurt W. Streams Principal Accounting Officer) * Director May 5, 1997 ------------------------ James J. Baker * Director May 5, 1997 ------------------------ Michael W. Huber * Director May 5, 1997 ------------------------ Robert L. Piccioni * Director May 5, 1997 ------------------------ Albert S. Waxman * By:/s/ Kurt W. Streams --------------------------- Kurt W. Streams Attorney-in-Fact 3 EX-27 2 EX.27-FDS SCHEDULE
5 This schedule contains summary information extracted from the financial statements in the Company's Annual Report on Form 10-K for the year ended December 31, 1996. 1 12-MOS DEC-31-1996 DEC-31-1996 8,133,468 1,949,039 10,779,477 221,000 1,851,713 22,893,284 481,421 75,046 30,243,378 3,722,513 0 0 0 3,452 26,517,413 30,243,378 24,648,928 25,309,977 16,248,469 16,248,469 6,075,878 0 0 3,689,374 1,498,000 2,191,374 0 0 0 2,191,374 0.31 0.31
-----END PRIVACY-ENHANCED MESSAGE-----